Skip to main content
2024 AATOD Conference Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Kenneth B. Stoller, MD (he/him/his)

Professor of Clinical Psychiatry
Johns Hopkins University School of Medicine
Baltimore, Maryland

Kenneth B. Stoller, MD, DLFAPA is the Director, Johns Hopkins Broadway Center for Addiction and a Professor of Clinical Psychiatry and Behavioral Sciences at Johns Hopkins University School of Medicine. He is also Medical Director, Behavioral Health, for Johns Hopkins Health Plans. His area of expertise is treatment of substance use problems and, in particular, the use of methadone and buprenorphine. His research interests have centered on cost issues as they relate to drug abuse and treatment, methods to enhance treatment adherence and retention, and co-occurring psychiatric, medical, pain, and substance use disorders (SUDs). Published manuscripts and book chapters focus on the use of adaptive stepped care, treatment incentives, and integrated treatment of co-occurring disorders in a single setting. He has a related focus on fostering policies and initiatives applied to health plans to improve health outcomes and value, such as improving detection of SUD and coordinating treatment of physical, mental health, and SUDs. Accelerated by his service on the board AATOD, and its Maryland state chapter, he refocused his work on increasing access to, and quality of, medication-assisted therapies in Baltimore, the region, and nationally. This work has received increasing attention, especially as it relates to coordinated care using opioid treatment programs as hubs of expertise that coordinate with community physicians prescribing buprenorphine. Dr. Stoller created and implemented the first known buprenorphine hub and spoke collaborative care model in the nation, and this is the subject of numerous presentations, webinars, and white papers.

Presentation(s):

Email Kenneth